Preferred Label : spesolimab;
MeSH hyponym : BI655130;
UNII : 5IB2J79MCX;
Origin ID : C000712973;
UMLS CUI : C5238146;
ATC code(s)
- Currated CISMeF NLP mapping
- MeSH term(s) associated for indexing
- Record concept(s)
- Semantic type(s)
- UMLS correspondences (same concept)
https://www.has-sante.fr/jcms/p_3576495/fr/spevigo-spesolimab-psoriasis-pustuleux-generalise-ppg
2025
false
false
false
France
insurance, health, reimbursement
treatment outcome
Generalized pustular psoriasis
Generalized pustular psoriasis flare
spesolimab
adult
adolescent
evaluation of the transparency committee
psoriasis
spesolimab
---
https://www.has-sante.fr/jcms/p_3594961/fr/spevigo-spesolimab-psoriasis-pustuleux-generalise-ppg-chez-l-adulte-et-l-adolescent
2025
false
false
false
France
treatment outcome
insurance, health, reimbursement
injections, subcutaneous
spesolimab
Generalized pustular psoriasis
Generalized pustular psoriasis flare
evaluation of the transparency committee
adolescent
spesolimab
adult
psoriasis
---
https://www.has-sante.fr/jcms/p_3423139/fr/spevigo-spesolimab-psoriasis-pustuleux-generalise-ppg
2024
false
false
false
France
Generalized pustular psoriasis
spesolimab
adult
treatment outcome
insurance, health, reimbursement
infusions, intravenous
evaluation of the transparency committee
psoriasis
spesolimab
---
https://www.ema.europa.eu/en/medicines/human/EPAR/spevigo
2023
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
spesolimab
spesolimab
spesolimab
psoriasis
Generalized pustular psoriasis
interleukin-36 receptor, human
adult
infusions, intravenous
product surveillance, postmarketing
aged
pregnancy
breast feeding
drug evaluation, preclinical
drug approval
europe
---
